Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Spatial transcriptomics of glioblastoma second surgery samples to compare progression and pseudoprogression

ABSTRACT: Spatial transcriptomics of glioblastoma second surgery samples to compare progression and pseudoprogression

PROVIDER: PRJNA970764 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24487100_1.fastq.gz	Fastqsanger.gz
	SRR24487100_2.fastq.gz	Fastqsanger.gz
	SRR24487200_1.fastq.gz	Fastqsanger.gz
	SRR24487200_2.fastq.gz	Fastqsanger.gz
	SRR24487101_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 384

Similar Datasets

Spatial transcriptomics of glioblastoma second surgery samples to compare progression and pseudoprogression

Project description:We performed spatial transcriptomics on a case series of different clinical subtypes of glioblastoma second surgery samples due to novel enhancement following chemoradiation that were confirmed based on clinico-pathologic outcome as disease progression (PD) or pseudoprogression (psPD). All samples showed mixed histologic presentation (Control, Inflammatory, or Hypercellular) which complicated disease interpretation by pathology. Our goals were to (1) determine if spatial transcriptomics could better distinguish between PD and psPD than bulk RNA approaches in mixed samples, (2) determine which differentially expressed genes (DEGs) and estimated immune cell populations distinguish PD and psPD in similar histologic sites, and (3) identify varying molcular processes through gene ontology that separate PD and psPD in similar presenting areas.

2023-12-04 | GSE232050 | GEO

Cancer-immune expressional variation in glioblastoma second surgery samples to compare progression and pseudoprogression

Project description:Cancer-immune expressional variation in glioblastoma second surgery samples to compare progression and pseudoprogression

| PRJNA970372 | ENA

Cancer-immune expressional variation in glioblastoma second surgery samples to compare progression and pseudoprogression

Project description:We performed cancer-immune gene expression analysis on a case series of glioblastoma second surgery samples due to novel enhancement following chemoradiation that were confirmed based on clinico-pathologic outcome as disease progression (PD) or pseudoprogression (psPD). This was accomplished using an nCounter Pancancer 360 IO panel. Our goals were to (1) determine if psPD events could be distinguished from PD events using differences in immune cell activation versus cancer cell proliferation and (2) examine whether samples stratified based on their molecular profile in the same way as documented clinico-pathologic diagnosis.

2023-12-04 | GSE231994 | GEO

Spatial transcriptomics (Visium) of first and second-trimester human gonads

Project description:Comprehensive map of first- and second-trimester gonadal development in humans using a combination of single-cell and spatial transcriptomics, chromatin accessibility assays, and imaging.

2022-05-03 | E-MTAB-10589 | biostudies-arrayexpress

Single Cell Spatial Analysis Reveals the Topology of Immunomodulatory Purinergic Signaling in Glioblastoma

Project description:Abstract from manuscript Glioblastoma develops an immunosuppressive microenvironment that fosters tumorigenesis and resistance to current therapeutic strategies. Here we use multiplexed tissue imaging and single-cell RNA-sequencing to characterize the composition, spatial organization, and clinical significance of extracellular purinergic signaling in glioblastoma. We show that glioblastoma exhibit strong expression of CD39 and CD73 ectoenzymes, correlating with increased adenosine levels. Microglia are the predominant source of CD39, while CD73 is principally expressed by tumor cells, particularly in tumors with amplification of EGFR and astrocyte-like differentiation. Spatially-resolved single-cell analyses demonstrate strong spatial correlation between tumor CD73 and microglial CD39, and that their spatial proximity is associated with poor clinical outcomes. Together, this data reveals that tumor CD73 expression correlates with tumor genotype, lineage differentiation, and functional states, and that core purine regulatory enzymes expressed by neoplastic and tumor-associated myeloid cells interact to promote a distinctive adenosine-rich signaling niche and immunosuppressive microenvironment potentially amenable to therapeutic targeting.

2022-06-27 | ST002203 | MetabolomicsWorkbench

Spatial transcriptomics (Visium) of first and second-trimester human gonads

Project description:Spatial transcriptomics (Visium) of first and second-trimester human gonads

| PRJEB54898 | ENA

Transcription profiling of human glioblastoma multiforme tumors taken before dendritic cell vaccination, recurrent tumors after vaccination and control GBM tumors

Project description:Human Glioblastoma Multiforme tumors taken before dendritic cell vaccination, the recurrent tumors taken after vaccination and control GBM tumors from non vaccinated patients. Experiment Overall Design: Six Glioblastoma Multiforme patients underwent surgery. Their brain tumors were removed and analyzed via microarray. The lysate from the tumors were cultured with the patients' dendritic cells and the DCs were injected back into the patients. The patients GBMs returned and they underwent surgery a second time and those tumors were also analyzed via microarray. Tumors from the first and second GBM surgeries of 5 patients who did not receive DC vaccines are included as controls.

2009-04-11 | E-GEOD-11100 | biostudies-arrayexpress

Glioblastoma disrupts cortical network activity at multiple spatial and temporal scales

Project description:The emergence of glioblastoma in cortical tissue initiates early and persistent neural hyperexcitability with signs ranging from mild cognitive impairment to convulsive seizures. The influence of peritumoral synaptic density, expansion dynamics, and spatial contours of excess glutamate upon higher order neuronal network modularity is unknown. We combined cellular and widefield imaging of calcium and glutamate fluorescent reporters in two glioblastoma mouse models with distinct synaptic microenvironments and infiltration profiles. Functional metrics of neural ensembles are dysregulated during tumor invasion depending on the stage of malignant progression and tumor cell proximity. Neural activity is differentially modulated during periods of accelerated and inhibited tumor expansion. Abnormal glutamate accumulation precedes and outpaces the spatial extent of baseline neuronal calcium signaling, indicating these processes are uncoupled in tumor cortex. Distinctive excitability homeostasis patterns and functional connectivity of local and remote neuronal populations support the promise of precision genetic diagnosis and management of this devastating brain disease.

2024-05-28 | GSE263832 | GEO

Integrative spatial analysis reveals a multi-layered organization of glioblastoma

Project description:Integrative spatial analysis reveals a multi-layered organization of glioblastoma

| PRJNA994130 | ENA

Salmonella compare pilot

Project description:Salmonella compare pilot

| PRJEB27347 | ENA